GSK shareholders to vote on Novartis deal on Dec 18
November 24, 2014 at 03:48 AM EST
LONDON (Reuters) - Britain's GlaxoSmithKline has asked its shareholders to vote at a meeting on Dec. 18 on its proposed major deal with Switzerland's Novartis, which will see the two pharmaceutical group trade more than $20 billion of assets.
